logologo
QuantliQuantli

News

/

Baker Hughes Sells Waygate Technologies for $1.45 Billion in Strategic Shift

NEWS

Market Mover

Baker Hughes Sells Waygate Technologies for $1.45 Billion in Strategic Shift

Suhaib

Executive summary

Baker Hughes agreed to sell its Waygate Technologies unit to Sweden's Hexagon for $1.45 billion in cash, marking the latest divestiture in the company's ongoing effort to streamline operations and focus on core energy technology businesses. The deal follows earlier asset sales and complements Baker Hughes' parallel $13.6 billion acquisition of Chart Industries.

What happened

Baker Hughes entered a definitive agreement to divest Waygate Technologies to Swedish industrial technology company Hexagon for $1.45 billion in an all-cash transaction. Waygate Technologies, based in Germany, provides non-destructive testing and inspection solutions used to evaluate the structural integrity of materials across various industries. The business operates in more than 80 countries, employs over 1,700 professionals, and generated approximately $630 million in revenue at a 10% earnings before interest and tax margin in fiscal 2025. The transaction is expected to close in the second half of 2026, pending regulatory approvals and customary closing conditions.

Why the stock moved

Market participants may be assessing the strategic implications of Baker Hughes continuing to shed non-core assets while pursuing transformative acquisitions. CEO Lorenzo Simonelli stated the company is sharpening its focus on core strengths to deliver higher returns while accelerating investment in high-growth areas. The $1.45 billion cash infusion will strengthen the company's balance sheet following earlier divestments this year of its Precision Sensors & Instrumentation division and Cactus Joint Venture unit. This capital management approach comes as Baker Hughes simultaneously pursues its planned $13.6 billion acquisition of Chart Industries.

Bigger picture

Baker Hughes is executing a deliberate portfolio transformation aimed at becoming a more focused energy technology company. The pattern of divesting specialty industrial businesses while investing heavily in energy transition plays reflects broader industry shifts driven by decarbonization trends and evolving energy demand. For Hexagon, acquiring Waygate Technologies expands its testing and inspection capabilities, with plans to drive margin improvement through manufacturing optimization, China localization, and revenue synergies. The deal represents another chapter in the ongoing consolidation and specialization occurring across industrial technology sectors as companies reposition for long-term market changes.

What investors watch

Investors will monitor whether Baker Hughes successfully closes both the Waygate divestiture and the Chart Industries acquisition on schedule, as these transactions collectively reshape the company's business mix. Execution on the stated goal of improving capital efficiency and cash flow while deploying proceeds into higher-growth energy technology segments will be crucial. Additionally, how effectively Baker Hughes integrates Chart Industries and whether the combined entity can capitalize on energy transition opportunities will determine if this strategic pivot delivers the promised shareholder returns. Regulatory approval timelines for both deals remain a near-term consideration.

This article was generated by Quantli AI using publicly available news sources.

#other
#company
#macro
#newsletter

Comments (0)

BKR

Baker Hughes Co

NASDAQ

•

Energy

$57.56

USD

-$0.29

(-0.50%)

At close: Jul 10, 2026, 4:00 PM EDT

Market Cap:

$56.64B

Volume:

4.9M

52w High:

$70.41

P/E Ratio:

21.88

View Company Page

Daily Analyst Ratings

Track how 1,000 Wall Street analysts rate stocks — updated daily.

See which S&P 500 stocks analysts expect to rise most.

View Top Upside Stocks

Top Gainers

ALNY

Alnylam Pharmaceuticals Inc

$378.05

+16.9%

SMPL

Simply Good Foods Co

$14.71

+14.6%

XHR

Xenia Hotels & Resorts Inc

$22.15

+12.0%

BBIO

BridgeBio Pharma Inc

$87.50

+11.7%

View all

Upcoming IPOs